KDM1A/ LSD1 inhibition enhances chemotherapy response in ovarian cancer

被引：0
|
作者：
Johnson, Jessica D.
Chen, Yihong
Jayamohan, Sridharan
He, Yi
Jamwal, Diksha
Pandey, Neetesh
Kost, Edward
Vadlamudi, Ratna K.
Sareddy, Gangadhara R.
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-3237
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3237
引用
收藏
页数：2
相关论文
共 50 条
  • [1] KDM1A/LSD1 inhibition enhances chemotherapy response in ovarian cancer
    Chen, Yihong
    Johnson, Jessica D.
    Jayamohan, Sridharan
    He, Yi
    Venkata, Prabhakar P.
    Jamwal, Diksha
    Alejo, Salvador
    Zou, Yi
    Lai, Zhao
    Viswanadhapalli, Suryavathi
    Vadlamudi, Ratna K.
    Kost, Edward
    Sareddy, Gangadhara R.
    MOLECULAR CARCINOGENESIS, 2024, 63 (10) : 2026 - 2039
  • [2] KDM1A/LSD1 inhibition enhances estrogen receptor beta mediated tumor suppression in ovarian cancer
    Venkata, Prabhakar P.
    Jayamohan, Sridharan
    He, Yi
    Alejo, Salvador
    Johnson, Jessica D.
    Pratap, Uday P.
    Viswanadhapalli, Suryavathi
    Weintraub, Susan
    Tekmal, Rajeshwar R.
    Vadlamudi, Ratna K.
    Kost, Edward
    Sareddy, Gangadhara R.
    CANCER RESEARCH, 2023, 83 (07)
  • [3] Pharmacological inhibition of KDM1A/LSD1 enhances estrogen receptor beta-mediated tumor suppression in ovarian cancer
    Venkata, Prabhakar Pitta
    Jayamohan, Sridharan
    He, Yi
    Alejo, Salvador
    Johnson, Jessica D.
    Palacios, Bridgitte E.
    Pratap, Uday P.
    Chen, Yihong
    Liu, Zexuan
    Zou, Yi
    Lai, Zhao
    Suzuki, Takayoshi
    Viswanadhapalli, Suryavathi
    Weintraub, Susan T.
    Palakurthi, Srinath
    Valente, Philip T.
    Tekmal, Rajeshwar R.
    Kost, Edward R.
    Vadlamudi, Ratna K.
    Sareddy, Gangadhara R.
    CANCER LETTERS, 2023, 575
  • [4] LSD1 (KDM1A)-independent effects of the LSD1 inhibitor SP2509 in cancer cells
    Sonnemann, Juergen
    Zimmermann, Miriam
    Marx, Christian
    Ebert, Franziska
    Becker, Sabine
    Lauterjung, Marie-Luise
    Beck, James F.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 183 (03) : 494 - 497
  • [5] Repression of LSD1/KDM1A activity improves the response of liver cancer cells to the lenvatinib
    Yi Zong
    Zhigang Tao
    Siyi Jiang
    Minyuan Wang
    Weihua Yu
    Discover Oncology, 15
  • [6] The histone demethylase LSD1/KDM1A promotes the DNA damage response
    Mosammaparast, Nima
    Kim, Haeyoung
    Laurent, Benoit
    Zhao, Yu
    Lim, Hui Jun
    Majid, Mona C.
    Dango, Sebastian
    Luo, Yuying
    Hempel, Kristina
    Sowa, Mathew E.
    Gygi, Steven P.
    Steen, Hanno
    Harper, J. Wade
    Yankner, Bruce
    Shi, Yang
    JOURNAL OF CELL BIOLOGY, 2013, 203 (03): : 457 - 470
  • [7] Repression of LSD1/KDM1A activity improves the response of liver cancer cells to the lenvatinib
    Zong, Yi
    Tao, Zhigang
    Jiang, Siyi
    Wang, Minyuan
    Yu, Weihua
    DISCOVER ONCOLOGY, 2024, 15 (01)
  • [8] Annual review of LSD1/KDM1A inhibitors in 2020
    Fu, Dong-Jun
    Li, Jun
    Yu, Bin
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 214
  • [9] Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma
    Pishas, Kathleen I.
    Sharma, Sunil
    Lessnick, Stephen L.
    CANCER RESEARCH, 2018, 78 (19)
  • [10] Therapeutic potential of targeting LSD1/KDM1A in cancers
    Zhang, Xiangyu
    Wang, Xinran
    Wu, Tianxiao
    Yin, Wenbo
    Yan, Jiangkun
    Sun, Yixiang
    Zhao, Dongmei
    PHARMACOLOGICAL RESEARCH, 2022, 175
12345